Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

Clinical trial NCT05068752 · COMPLETED

Trial details

NCT number: NCT05068752
Sponsor: HonorHealth Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer

Start date: 2021-10-28
Primary completion: 2024-11-08
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.